Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |